跳至主要内容
临床试验/NCT05866887
NCT05866887已完成不适用

Insomnia Prevention in Children With Acute Lymphoblastic Leukemia

Dana-Farber Cancer Institute4 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2023年9月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
25
试验地点
4
主要终点
Enrollment Rate of Participants

研究概览

简要总结

The goal of this research study is to understand the acceptability and feasibility of the Sleep ALL Night intervention among children with Acute Lymphoblastic Leukemia (ALL) in hopes of improving the discussion of sleep disorders with clinical providers.

The name of the intervention used in this research study is: Sleep ALL Night, which is a sleep intervention program comprised of an action plan tool and psychoeducational website.

详细描述

This research study is to conduct a single-arm pilot study to determine the acceptability and feasibility of Sleep ALL Night for children with Acute Lymphoblastic Leukemia (ALL).

Participation in this research study is expected to last 1 month.

It is expected about 30 children will take part in this research study.

The National Cancer Institute (NCI) is providing funding for this research study through a grant.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
4 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Patient in the Maintenance Phase of therapy on or as per DFCI 16-001 and has completed at least two cycles of maintenance therapy to allow adequate recovery from the more intensive Consolidation phase.
  • English or Spanish speaking child and primary caregiver (parent/guardian).
  • Child aged 4-12 years.

排除标准

  • Primary team declines permission to approach.
  • Children with critical illness (defined as ICU admission)

结局指标

主要结局

Enrollment Rate of Participants

时间窗: At screening, when eligible participants are approached by research staff. Recruitment occurred over a 5-month period.

The primary study outcome of acceptability is defined as the proportion of eligible participants who are approached by research staff who agree to participate in the study, with the cutoff set at ≥30% of eligible participants who are approached agreeing to participate.

Acceptability of Intervention Measure Scale Score

时间窗: At Week 4

The primary study outcome of acceptability is defined as participants reporting an average score of ≥4 ("Agree") on the Acceptability of Intervention Measure scale, a four-item questionnaire assessing the acceptability of an intervention. The scale uses a 5-point scale with options ranging from Completely Agree (5) to Completely Disagree (1). The average score of all four items was used as the primary outcome. A higher score indicates greater belief that the intervention was acceptable for the participant.

Intervention Assessment Completion Rate

时间窗: Up to 1 month after the conclusion of the study period, up to 8 weeks.

The primary study outcome of feasibility is defined as ≥80% of enrolled participants complete the Post-Intervention Assessment.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eric Zhou, PhD

Principal Investigator

Dana-Farber Cancer Institute

研究点 (4)

Loading locations...

相似试验

相关资讯